Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF
暂无分享,去创建一个
P. Falkai | W. Maier | T. Suslow | V. Arolt | P. Ohrmann | M. Rothermundt | A. Pedersen | H. Bürkle | M. Peters | G. Ponath | M. Peters | M. Diedrich | A. Siegmund | G. Hetzel | J. Schramm | S. Abel | P. Falkai | Wolfgang Maier
[1] V. Arolt,et al. S100B Serum Levels and Long-Term Improvement of Negative Symptoms in Patients with Schizophrenia , 2004, Neuropsychopharmacology.
[2] V. Arolt,et al. S100B in brain damage and neurodegeneration , 2003, Microscopy research and technique.
[3] M. Trojano,et al. Quality Assurance for Cerebrospinal Fluid Protein Analysis: International Consensus by an Internet-Based Group Discussion , 2003, Clinical chemistry and laboratory medicine.
[4] C. Heizmann,et al. S100 proteins: structure, functions and pathology. , 2002, Frontiers in bioscience : a journal and virtual library.
[5] M. Wiesmann,et al. Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology , 2001, Molecular Psychiatry.
[6] D. Souza,et al. Increased serum S100B protein in schizophrenia: a study in medication-free patients. , 2001, Journal of psychiatric research.
[7] R. Hoffman,et al. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. , 2000, Archives of general psychiatry.
[8] A. Araque,et al. Tripartite synapses: glia, the unacknowledged partner , 1999, Trends in Neurosciences.
[9] P. Goldman-Rakic,et al. The reduced neuropil hypothesis: a circuit based model of schizophrenia , 1999, Biological Psychiatry.